Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-25-000121 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
97.02% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.98% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
43.10% · OPTIONAL · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
23.87% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
3.55% · OPTIONAL · VALID
Gross margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
67.77% · CORE · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
39.89% · CORE · VALID
R&D intensity 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.18% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.85% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 9/9 normalized Level 3 Jan 29, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 30, 2023 9/9 normalized Level 3 Oct 29, 2023 9/9 normalized Level 3 Feb 4, 2024 9/9 normalized Level 3 May 5, 2024 9/9 normalized Level 3 Aug 4, 2024 9/9 normalized Level 3 Nov 3, 2024 9/9 normalized Level 3 Feb 2, 2025 9/9 normalized Level 3 May 4, 2025 9/9 normalized Level 3 Aug 3, 2025 9/9 normalized Level 3 Nov 2, 2025 9/9 normalized Level 3 Feb 1, 2026 9/9 normalized Level 3 May 3, 2026 9/9 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 393.87%
Current 97.02%
Delta -296.85% Capex Intensity Increased
Previous 0.89%
Current 0.98%
Delta 0.09% Cash Generation Decreased
Previous 44.92%
Current 43.10%
Delta -1.82% Growth Increased
Previous 22.03%
Current 23.87%
Delta 1.84% Inventory Pressure Decreased
Previous 13.67%
Current 3.55%
Delta -10.11% Margin Increased
Previous 67.09%
Current 67.77%
Delta 0.67% Profitability Increased
Previous 36.90%
Current 39.89%
Delta 2.98% R And D Intensity Decreased
Previous 19.12%
Current 17.18%
Delta -1.94% Sbc Intensity Decreased
Previous 14.56%
Current 11.85%
Delta -2.71% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.